ArticleScientific reports2026
Bio-functionalities of nitrogen based carbon dots from chitosan via in-situ incorporation with nano-copper.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent researches were considerably interested in the biological performance of carbon dots as a unique member of carbon based-nanomaterials to find widely applicability in various purposes. This study investigates the direct incorporation of nano-copper within nitrogen based carbon quantum dots (N-CQDs) that were formerly ingrained from carboxy-methylated chitosan, via hydrothermal conditions without any reducing agent for biomedical applications. Copper was incorporated using three precursors including copper sulphate, copper nitrate, and copper acetate, yielding Cu(S)@N-CQDs, Cu(N)@N-CQDs, and Cu(C)@N-CQDs, respectively. Carboxy-methylated chitosan was firstly synthesized from chitosan via interaction with chloro-acetic acid. Non-doped N-CQDs exhibited an average particle size of 9.6 nm, while Cu(S)@N-CQDs, Cu(N)@N-CQDs, and Cu(C)@N-CQDs displayed increased sizes of 43.3 nm, 24.8 nm, and 40.7 nm, reflecting the distinct effects of precursor chemistry on particle growth. Cu doping significantly enhanced the biological functionalities of N-CQDs, including antimicrobial, antioxidant, and anti-inflammatory activities. Against Staphylococcus aureus, Cu(N)@N-CQDs achieved the highest bacterial reduction (89%), followed by Cu(C)@N-CQDs (87%) and Cu(S)@N-CQDs (84%), compared to 52% for undoped N-CQDs. Consistently, Cu(N)@N-CQDs also demonstrated superior antioxidant capacity (79.8% DPPH scavenging) and anti-inflammatory performance (68.1% cell viability), highlighting the pivotal role of precursor-dependent Cu incorporation in optimizing N-CQD bioactivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.